VTC Ventures

VTC Ventures, established in 2017 and located in Roanoke, Virginia, is a venture capital firm that focuses on investing in early-stage life sciences and high-growth technology companies. The firm targets a diverse range of sectors, including biopharmaceuticals, pharmaceuticals, medical technology, biotechnology, agriculture, and advanced manufacturing, among others. VTC Ventures employs two main investment vehicles: the VTC Innovation Fund, which supports Series A and B investments, and the VTC Seed Fund, dedicated to seed-stage investments. The firm primarily seeks opportunities within the Mid Atlantic and Virginia regions, aiming to foster innovation and growth in a variety of industries.

Kody Cobb

Senior Associate

6 past transactions

EarthOptics

Venture Round in 2024
EarthOptics is a developer of a global soil cloud platform aimed at sustainable agricultural management. The company utilizes advanced sensors and machine learning techniques to create highly accurate soil maps based on minimal soil samples. Its technology provides insights into various soil attributes, including compaction, fertility, and carbon levels. This information enables farmers, ranchers, and land managers to make informed and sustainable soil management decisions, which can lead to improved profitability and environmental stewardship. Additionally, EarthOptics offers near-real-time actionable data that enhances soil health management and provides cost-effective verification for carbon credits.

EarthOptics

Series B in 2023
EarthOptics is a developer of a global soil cloud platform aimed at sustainable agricultural management. The company utilizes advanced sensors and machine learning techniques to create highly accurate soil maps based on minimal soil samples. Its technology provides insights into various soil attributes, including compaction, fertility, and carbon levels. This information enables farmers, ranchers, and land managers to make informed and sustainable soil management decisions, which can lead to improved profitability and environmental stewardship. Additionally, EarthOptics offers near-real-time actionable data that enhances soil health management and provides cost-effective verification for carbon credits.

BIOHM

Seed Round in 2023
BIOHM is a pioneering microbiome company focused on enhancing digestive health by addressing the role of fungi alongside bacteria. With over 20 years of research backed by the National Institutes of Health, Dr. Ghannoum has developed a unique understanding of how harmful bacteria and fungi interact to create digestive plaque, a barrier that disrupts gut balance. BIOHM offers a range of whole probiotics and gut microbiome testing kits designed to educate consumers about their gut health. The company’s innovative products utilize dual-action technology to break down digestive plaque and neutralize harmful microorganisms, thereby promoting a balanced microbiome. By providing personalized insights into gut health, BIOHM empowers individuals to make informed choices regarding their diet, lifestyle, and supplements to optimize their digestive well-being.

ModifyHealth

Series B in 2023
ModifyHealth is a digital health platform focused on improving health outcomes and reducing costs for individuals with chronic conditions such as diabetes, heart disease, and kidney disease. The company offers a meal delivery service that provides fully-prepared, nutritious meals tailored to support dietary management for these conditions. Its menu includes gluten-free and low-FODMAP options to help manage various symptoms. In addition to meal delivery, ModifyHealth provides dietitian coaching and remote patient monitoring, ensuring sustained health benefits through personalized support and guidance. This approach simplifies the integration of food as medicine into daily life, enhancing the overall well-being of its customers.
Veracity Verification Solutions bridges the gap between EdTech and Educators through merit-based verification system.

Discure

Seed Round in 2022
Discure Technologies is developing a minimally invasive, implantable bioelectronic device designed to treat and reverse degenerative disc disease (DDD), healing the disc, reducing pain, and restoring function to patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.